Cited 0 times in

두경부암의 최신 표적치료

Other Titles
 What’s New in Molecular Targeted Therapies for Head and Neck Cancer? 
Authors
 이서영  ;  김혜련 
Citation
 Korean Journal of Head & Neck Oncology(대한두경부종양학회지), Vol.37(2) : 11-17, 2021-11 
Journal Title
Korean Journal of Head & Neck Oncology(대한두경부종양학회지)
ISSN
 1229-5183 
Issue Date
2021-11
Keywords
Head and neck squamous cell carcinoma ; Targeted therapy ; Molecular pathway
Abstract
Head and neck cancer is the 6th most frequently diagnosed solid tumor in the world. Alcohol consumption, smoking, and HPV infection are associated with the incidence of head and neck squamous cell carcinoma (HNSCC). Although a multidisciplinary approach is a key strategy for the treatment of locally advanced HNSCC, systemic therapy is the mainstream of recurrent or metastatic HNSCC treatment. Stage IV HNSCC has a relatively poor prognosis with median overall survival of around one year. There have been many clinical trials to investigate the efficacy of target agents in the treatment of HNSCC. In the HPV-negative HNSCC, TP53 and CDKN2A are the most commonly mutated genes. In the HPV-positive HNSCC, the PI3K pathway is frequently altered. EGFR, PI3K, cell cycle pathway, MET, HRAS, and IL6/JAK/STAT pathway are explored targets in HNSCC. In this study, we review the target pathways and agents under research. We also introduce here umbrella trials of recurrent or metastatic HNSCC conducted by the Korea Cancer Study Group. The combination of target agents with immune checkpoint inhibitors or cytotoxic chemotherapies would be a future step in the precision medicine of HNSCC treatment.
Files in This Item:
T202204344.pdf Download
DOI
10.21593/kjhno/2021.37.2.11
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Hye Ryun(김혜련) ORCID logo https://orcid.org/0000-0002-1842-9070
Lee, Seoyoung(이서영)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190617
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links